The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
Open accessAbstract
BACKGROUND/OBJECTIVE: Anti-inflammatory drugs may prevent Parkinson disease (PD) by inhibiting a putative underlying neuroinflammatory process. We tested the hypothesis that anti-inflammatory drugs reduce PD incidence and that there are differential effects by type of anti-inflammatory, duration of use, or intensity of use. METHODS: MEDLINE and EMBASE were searched for studies that reported risk of PD associated with anti-inflammatory medications. Random-effects meta-analyses were used to pool results across studies for each type of anti-inflammatory drug. Stratified meta-analyses were used to assess duration- and intensity-response. RESULTS: Seven studies were identified that met the inclusion criteria, all of which reported associations between nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) and PD, 6 of which reported on aspirin, and 2 of which reported on acetaminophen. Overall, a 15% reduction in PD incidence was observed among users of nonaspirin NSAIDS (relative risk [RR] 0.85, 95% confidence interval [CI] 0.77-0.94), with a similar effect observed for ibuprofen use. The protective effect of nonaspirin NSAIDs was more pronounced among regular users (RR 0.71, 95% CI 0.58-0.89) and long-term users (RR 0.79, 95% CI 0.59-1.07). No protective effect was observed for aspirin (RR 1.08, 95% CI 0.92-1.27) or acetaminophen (RR 1.06, 95% CI 0.87-1.30). Sensitivity analyses found results to be robust. CONCLUSIONS: There may be a protective effect of nonaspirin nonsteroidal anti-inflammatory drug use on risk of Parkinson disease (PD) consistent with a possible neuroinflammatory pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Blomkalns, A. L., Chen, A. Y., Hochman, J. S., Peterson, E. D., Trynosky, K., Diercks, D. B., Brogan, G. X., Boden, W. E., Roe, M. T., Ohman, E. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.055 · Cited by 653
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Chen, H., Jacobs, E., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Annals of Neurology · doi:10.1002/ana.20682 · Cited by 472
Neuroinflammatory processes in Parkinson's disease
Hunot, S., & Hirsch, E. C. (2003) · Annals of Neurology · doi:10.1002/ana.10481 · Cited by 398
Laparoscopic Versus Open Surgery for Rectal Cancer: A Meta-Analysis
Aziz, O., Constantinides, V., Tekkis, P. P., Athanasiou, T., Purkayastha, S., Paraskeva, P., Darzi, A. W., & Heriot, A. G. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.045 · Cited by 392
Treatment of Acute Myocardial Infarction and 30-Day Mortality among Women and Men
Gan, S. C., Beaver, S. K., Houck, P. M., MacLehose, R. F., Lawson, H. W., & Chan, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430102 · Cited by 356
Chandra, N. C. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.9.981 · Cited by 334
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
Liu, B., Gao, H.-M., & Hong, J.-S. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6361 · Cited by 285
Paul-Clark, M. J., van Cao, T., Moradi-Bidhendi, N., Cooper, D., & Gilroy, D. W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040566 · Cited by 236
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Esposito, E., Di Matteo, V., Benigno, A., Pierucci, M., Crescimanno, G., & Di Giovanni, G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.008 · Cited by 234
ARONOFF, D., OATES, J., & BOUTAUD, O. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.009 · Cited by 222
Millett, G. A. (2008) · JAMA · doi:10.1001/jama.300.14.1674 · Cited by 220
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Wahner, A. D., Bronstein, J. M., Bordelon, Y. M., & Ritz, B. (2007) · Neurology · doi:10.1212/01.wnl.0000279519.99344.ad · Cited by 213
Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study
Driver, J. A., Kurth, T., Buring, J. E., Gaziano, J. M., & Logroscino, G. (2008) · Neurology · doi:10.1212/01.wnl.0000310414.85144.ee · Cited by 165
Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease
Wahner, A. D., Sinsheimer, J. S., Bronstein, J. M., & Ritz, B. R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.836 · Cited by 162
Samii, A., Etminan, M., Wiens, M. O., & Jafari, S. (2009) · Drugs & Aging · doi:10.2165/11316780-000000000-00000 · Cited by 161
Cigarette Smoking and Dementia: Potential Selection Bias in the Elderly
Hernán, M. A., Alonso, A., & Logroscino, G. (2008) · Epidemiology · doi:10.1097/ede.0b013e31816bbe14 · Cited by 159
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk
Powers, K. M., Kay, D. M., Factor, S. A., Zabetian, C. P., Higgins, D. S., Samii, A., Nutt, J. G., Griffith, A., Leis, B. C., Roberts, J. W., et al. (2007) · Movement Disorders · doi:10.1002/mds.21782 · Cited by 144
Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease
Ton, T. G. N., Heckbert, S. R., Longstreth, W. T., Jr., Rossing, M. A., Kukull, W. A., Franklin, G. M., Swanson, P. D., Smith‐Weller, T., & Checkoway, H. (2006) · Movement Disorders · doi:10.1002/mds.20856 · Cited by 141
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease
Hernán, M. Á., Logroscino, G., & Rodríguez, L. A. G. (2006) · Neurology · doi:10.1212/01.wnl.0000204446.82823.28 · Cited by 139
Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study
Bower, J. H., Maraganore, D. M., Peterson, B. J., Ahlskog, J. E., & Rocca, W. A. (2006) · Neurology · doi:10.1212/01.wnl.0000227906.99570.cc · Cited by 113
Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease
Hancock, D. B., Martin, E. R., Stajich, J. M., Jewett, R. M., Stacy, M. A., Scott, B. L., Vance, J. M., & Scott, W. K. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.576 · Cited by 109
Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease
Hancock, D. B., Martin, E. R., Vance, J. M., & Scott, W. K. (2008) · Neurogenetics · doi:10.1007/s10048-008-0137-1 · Cited by 107
Håkansson, A., Westberg, L., Nilsson, S., Buervenich, S., Carmine, A., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30136 · Cited by 90
Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Bornebroek, M., de Lau, L. M. L., Haag, M. D. M., Koudstaal, P. J., Albert Hofman, D., Stricker, B. H. C., & Breteler, M. M. B. (2007) · Neuroepidemiology · doi:10.1159/000108110 · Cited by 77
Etminan, M., Carleton, B., & Samii, A. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.02.095 · Cited by 64
Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-analysis
Ganti, L., Gilmore, R. M., Bellolio, F., Rabinstein, A. A., & Decker, W. W. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1024 · Cited by 47
USE OF ANTIHYPERTENSIVES AND THE RISK OF PARKINSON DISEASE
Ascherio, A., & Tanner, C. M. (2009) · Neurology · doi:10.1212/01.wnl.0000344171.22760.24 · Cited by 31
Common anti-inflammatory drugs are potentially therapeutic for Parkinson’s disease?
Asanuma, M., & Miyazaki, I. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.006 · Cited by 31
NSAID Use and the Risk of Parkinsons Disease
Etminan, M., & Suissa, S. (2006) · Current Drug Safety · doi:10.2174/157488606777934404 · Cited by 27
Gagne, J. J., Griesdale, D. E. G., & Schneeweiß, S. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1714 · Cited by 25
Self-citation
Cited by
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884
Metadata
- Authors
- Gagne, J. J., & Power, M. C.
- Venue
- Neurology
- Published
- 2010-03-23
- Volume
- 74
- Issue
- 12
- Pages
- 995-1002
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1993829231
- Cited by
- 322
- References
- 38
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.